Melhores Terapia SIRT médicos em Israel - TOP-9 médicos

O Prof. Merimsky lidera a Unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center – um dos principais departamentos de oncologia de Israel.

• Mais de 25 anos de especialização em sarcoma e tumores ósseos
• Treinamento de *fellowship* realizado no Institut Gustave Roussy, em Paris
• Membro da Faculdade de Sarcoma da ESMO e da ASCO
• Publicou extensivamente sobre tratamentos de oncologia ortopédica

A Dra. Pelles Sharon é especialista em terapia SIRT no Sourasky Medical Center, trazendo vasta experiência em tratamentos avançados contra o câncer.

• Oncologista altamente respeitada com contribuições notáveis para a pesquisa clínica
• Realiza uma ampla gama de cirurgias e terapias oncológicas
• Especialista em quimioterapia intraperitoneal hipertérmica (HIPEC)
• Habilidosa em imunoterapia e abordagens de terapia alvo

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

O Dr. Greenberg chefia o Departamento de Cirurgia Colorretal no Centro Médico Sourasky, com mais de 20 anos de experiência cirúrgica.

• Especializa-se tanto em técnicas abertas quanto minimamente invasivas
• Especialista em procedimentos de cirurgia de Whipple
• Trabalha em um dos principais centros médicos de Israel

Diretor de internação oncológica no Centro Médico de Tel Aviv – Dr. Stepfansky é especializado em terapia SIRT e possui vasta experiência em pesquisa clínica.

• Mais de 15 anos de prática em oncologia
• Pesquisador principal em múltiplos ensaios clínicos
• Formado no Centro Médico de Tel Aviv
• Especializado em medicina interna e oncologia

Mais de 28 anos de especialização em cânceres de fígado e pâncreas – O Dr. Ben-haim é um especialista líder em oncologia gastrointestinal complexa no Sourasky Medical Center.

• Realiza a cirurgia de Whipple e outras intervenções avançadas
• Foca-se exclusivamente em casos de oncologia gastrointestinal
• Reconhecido como um dos principais especialistas em câncer de fígado de Israel

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.